Universidade Federal do Rio de Janeiro

Rio de Janeiro cep: 21941.590

2 studies enrolling now · 6 studies all time

What they study most

Diabetes Mellitus, Type 1, Genetic Diseases, Inborn, Genetic Diseases, X-Linked, Metabolic Dysfunction-Associated Steatotic Liver Disease, Muscular Diseases, Muscular Disorders, Atrophic, Muscular Dystrophies, Muscular Dystrophy, Duchenne, Musculoskeletal Disease, Nervous System Diseases, Neuromuscular Diseases, Tuberculosis

Studies at this site

• A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) — Recruiting now
• A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults — Recruiting now
• A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE) — Recruiting now
• Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy — Completed
• Three Months of Weekly Rifapentine and Isoniazid for M. Tuberculosis Infection — Completed
• Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis — Completed